Strategies for the treatment of antidepressant-related sexual dysfunctionZAJECKA, John.The Journal of clinical psychiatry. Supplement. 2001, Vol 62, Num 3, pp 35-43Conference Paper

Residual Symptoms and Relapse: Mood, Cognitive Symptoms, and Sleep DisturbancesZAJECKA, John M.The Journal of clinical psychiatry. 2013, Vol 74, pp 9-13, issn 0160-6689, 5 p., SUP2Article

Augmentation strategies to increase antidepressant tolerabilityZAJECKA, John M.The Journal of clinical psychiatry. Supplement. 2007, Vol 68, Num 10, pp 23-27, 5 p.Article

Nefazodone: Discontinuation issues and safety in chronic major depressionZAJECKA, John; BAILEY, Lagenia.The Journal of clinical psychiatry. Supplement. 2002, Vol 63, Num 1, pp 36-38Article

The Modified Rush Sexual Inventory : Preliminary psychometric findingsRAO, Deepa; ZAJECKA, John; SKUBIAK, Taisa et al.Psychiatry research. 2005, Vol 137, Num 3, pp 175-181, issn 0165-1781, 7 p.Article

Residual Symptoms in Major Depressive Disorder: Prevalence, Effects, and ManagementZAJECKA, John; KORNSTEIN, Susan G; BLIER, Pierre et al.The Journal of clinical psychiatry. 2013, Vol 74, Num 4, pp 407-414, issn 0160-6689, 8 p.Article

Treating depression to remissionZAJECKA, John M.The Journal of clinical psychiatry. Supplement. 2003, Vol 64, Num 15, pp 7-12, 6 p.Article

Antidepressant dosing and switching guidelines: Focus on nefazodoneZAJECKA, John; MCENANY, Geoffry W; LUSK, Kimberly M et al.The Journal of clinical psychiatry. Supplement. 2002, Vol 63, Num 1, pp 42-47Article

SNRIs in the management of acute major depressive disorderZAJECKA, John M; ALBANO, Dominick.The Journal of clinical psychiatry. Supplement. 2004, Vol 65, Num 17, pp 11-18, 8 p.Article

Symptomatic and syndromal anxiety in chronic forms of major depression: Effect of nefazodone, Cognitive Behavioral Analysis System of Psychotherapy, and their combinationNINAN, Philip T; RUSH, A. John; KELLER, Martin B et al.The Journal of clinical psychiatry. 2002, Vol 63, Num 5, pp 434-441, issn 0160-6689Article

A double-blind, randomized trial of St John's wort, fluoxetine, and placebo in major depressive disorderFAVA, Maurizio; ALPERT, Jonathan; NIERENBERG, Andrew A et al.Journal of clinical psychopharmacology. 2005, Vol 25, Num 5, pp 441-447, issn 0271-0749, 7 p.Article

Efficacy and safety of mirtazapine in major depressive disorder patients after SSRI treatment failure : An open-label trialFAVA, Maurizio; DUNNER, David L; GREIST, John H et al.The Journal of clinical psychiatry. 2001, Vol 62, Num 6, pp 413-420, issn 0160-6689Article

Lack of sexual dysfunction with the selective noradrenaline reuptake inhibitor reboxetine during treatment for major depressive disorderCLAYTON, Anita H; ZAJECKA, John; FERGUSON, James M et al.International clinical psychopharmacology. 2003, Vol 18, Num 3, pp 151-156, issn 0268-1315, 6 p.Article

Pharmacotherapy of depression and mixed states in bipolar disorderMONTGOMERY, Stuart A; SCHATZBERG, Alan F; GUELFI, J. D et al.Journal of affective disorders. 2000, Vol 59, pp S39-S56, issn 0165-0327, SUP1Conference Paper

The use of referenced-EEG (rEEG) in assisting medication selection for the treatment of depressionDEBATTISTA, Charles; KINRYS, Gustavo; BRANDT, Len et al.Journal of psychiatric research. 2011, Vol 45, Num 1, pp 64-75, issn 0022-3956, 12 p.Article

Olanzapine versus divalproex sodium for the treatment of acute Mania and maintenance of remission: A 47-week studyTOHEN, Mauricio; KETTER, Terence A; BAKER, Robert W et al.The American journal of psychiatry. 2003, Vol 160, Num 7, pp 1263-1271, issn 0002-953X, 9 p.Article

Development and validation of a screening instrument for Bipolar spectrum disorder : The Mood Disorder QuestionnaireHIRSCHFELD, Robert M. A; WILLIAMS, Janet B. W; RUSSELL, James M et al.The American journal of psychiatry. 2000, Vol 157, Num 11, pp 1873-1875, issn 0002-953XArticle

Vagus nerve stimulation for treatment-resistant depression : A randomized, controlled acute phase trialRUSH, A. John; MARANGELL, Lauren B; RAPAPORT, Mark H et al.Biological psychiatry (1969). 2005, Vol 58, Num 5, pp 347-354, issn 0006-3223, 8 p.Article

Randomized, placebo-controlled trial of nefazodone maintenance treatment in preventing recurrence in chronic depressionGELENBERG, Alan J; TRIVEDI, Madhukar H; KEITNER, Gabor I et al.Biological psychiatry (1969). 2003, Vol 54, Num 8, pp 806-817, issn 0006-3223, 12 p.Article

Sexual function and satisfaction in the treatment of chronic major depression with nefazodone, psychotherapy, and their combinationZAJECKA, John; DUNNER, David L; BORIAN, Frances E et al.The Journal of clinical psychiatry. 2002, Vol 63, Num 8, pp 709-716, issn 0160-6689Article

Divalproex sodium versus olanzapine in the treatment of acute Mania in bipolar disorder: Health-related Quality of Life and medical cost outcomesREVICKI, Dennis A; PARAMORE, L. Clark; SOMMERVILLE, Kenneth W et al.The Journal of clinical psychiatry. 2003, Vol 64, Num 3, pp 288-294, issn 0160-6689, 7 p.Article

Intramuscular ziprasidone, 2 mg versus 10 mg, in the short-term management of agitated psychotic patientsLESEM, Michael D; ZAJECKA, John M; SWIFT, Rachel H et al.The Journal of clinical psychiatry. 2001, Vol 62, Num 1, pp 12-18, issn 0160-6689Article

A comparison of the efficacy, safety, and tolerability of divalproex sodium and olanzapine in the treatment of bipolar disorderZAJECKA, John M; WEISLER, Richard; SACHS, Gary et al.The Journal of clinical psychiatry. 2002, Vol 63, Num 12, pp 1148-1155, issn 0160-6689, 8 p.Article

A randomized, double-blind, active-control study of sertraline versus venlafaxine XR in major depressive disorderSHELTON, Richard C; HAMAN, Kirsten L; RAPAPORT, Mark H et al.The Journal of clinical psychiatry. 2006, Vol 67, Num 11, pp 1674-1681, issn 0160-6689, 8 p.Article

High-dose sertraline strategy for nonresponders to acute treatment for obsessive-compulsive disorder : A multicenter double-blind trialNINAN, Philip T; KORAN, Lorrin M; KIEV, Ari et al.The Journal of clinical psychiatry. 2006, Vol 67, Num 1, pp 15-22, issn 0160-6689, 8 p.Article